Three more I-Mab ex­ecs ex­it af­ter US/Chi­na op­er­a­tions split

As I-Mab Bio­phar­ma em­barks on its next chap­ter as a ful­ly US-based com­pa­ny, it’s part­ing ways with more ex­ec­u­tives from the old era.

Chief Busi­ness Of­fi­cer Weimin Tang, Chief Com­mu­ni­ca­tions Of­fi­cer Gi­gi Qi Feng and Chief Le­gal Of­fi­cer Richard Cheng Li have re­signed from their re­spec­tive po­si­tions, ef­fec­tive March 31, I-Mab dis­closed in an SEC fil­ing. “None of these res­ig­na­tions were due to any dis­agree­ment with the Com­pa­ny,” it wrote, adding that it’s search­ing for a new chief busi­ness of­fi­cer and chief le­gal of­fi­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER